Variant report
Variant | nsv874917 |
---|---|
Chromosome Location | chr2:115723034-115788593 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72945854 | chr2:115749437-115749438 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs541192413 | chr2:115749439-115749440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs67318469 | chr2:115749457-115749458 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs574596508 | chr2:115749518-115749519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78925115 | chr2:115749538-115749539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563472640 | chr2:115749568-115749569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183200630 | chr2:115749570-115749571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs570300376 | chr2:115749805-115749806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78322315 | chr2:115749815-115749816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554206571 | chr2:115749890-115749891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186681705 | chr2:115749903-115749904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146126074 | chr2:115749919-115749920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138997257 | chr2:115749934-115749935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535125195 | chr2:115749971-115749972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533649691 | chr2:115750028-115750029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554762182 | chr2:115750039-115750040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547679449 | chr2:115750062-115750063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574563323 | chr2:115750070-115750071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543296692 | chr2:115750076-115750077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs906913 | chr2:115750093-115750094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577100300 | chr2:115750101-115750102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545361763 | chr2:115750118-115750119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558948386 | chr2:115750177-115750178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34245669 | chr2:115750195-115750196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373385939 | chr2:115750262-115750263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376356731 | chr2:115750294-115750295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371278596 | chr2:115750302-115750303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574995127 | chr2:115750303-115750304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189527268 | chr2:115750347-115750348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540446096 | chr2:115750351-115750352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183345193 | chr2:115750438-115750439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550136707 | chr2:115750466-115750467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570295257 | chr2:115750478-115750479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532877047 | chr2:115750501-115750502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187835237 | chr2:115750558-115750559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs141587054 | chr2:115750562-115750563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139017241 | chr2:115751082-115751083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149888558 | chr2:115751085-115751086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187515282 | chr2:115751115-115751116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs67544881 | chr2:115751142-115751143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs71394121 | chr2:115751157-115751158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs59643647 | chr2:115751159-115751160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs59593945 | chr2:115751177-115751178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs70941018 | chr2:115751184-115751185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114762785 | chr2:115751216-115751217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140402011 | chr2:115751242-115751243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184756768 | chr2:115751243-115751244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188298062 | chr2:115751262-115751263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376517694 | chr2:115751263-115751264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs77995149 | chr2:115751285-115751286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Mental retardation | 17621639 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:115749400-115749600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:115749800-115750200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr2:115749800-115750600 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr2:115750000-115750600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr2:115751000-115757200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr2:115751400-115751600 | Enhancers | Fetal Brain Male | brain |
7 | chr2:115752400-115752800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:115752800-115756000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr2:115756000-115756800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr2:115756800-115757200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr2:115757200-115757400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr2:115757200-115757400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr2:115757400-115759600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr2:115759600-115759800 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr2:115777000-115777400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |